Novavax
NVAX
#5908
Rank
NZ$2.13 B
Marketcap
NZ$12.99
Share price
3.37%
Change (1 day)
13.75%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -NZ$0.13 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$0.59 Billion. In 2025 the company made an earning of NZ$0.78 Billion, an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.13 Billion-115.31%
2025 NZ$0.78 B-396.87%
2024 -NZ$0.27 Billion-70.39%
2023 -NZ$0.9 Billion-16.59%
2022 -NZ$1.08 Billion-62.58%
2021 -NZ$2.88 Billion320.54%
2020 -NZ$0.69 Billion234.22%
2019 -NZ$0.21 Billion-30.17%
2018 -NZ$0.3 Billion1.69%
2017 -NZ$0.29 Billion-36.44%
2016 -NZ$0.46 Billion70.4%
2015 -NZ$0.27 Billion89.27%
2014 -NZ$0.15 Billion59.83%
2013 -NZ$87.87 Million81.9%
2012 -NZ$48.31 Million50.33%
2011 -NZ$32.14 Million
2009 -NZ$63.42 Million8.8%
2008 -NZ$58.29 Million18.01%
2007 -NZ$49.4 Million18.33%
2006 -NZ$41.75 Million168.31%
2005 -NZ$15.56 Million-62.51%
2004 -NZ$41.5 Million52.4%
2003 -NZ$27.24 Million-28.21%
2002 -NZ$37.93 Million
2000 -NZ$21.62 Million177%
1999 -NZ$7.81 Million-11.54%
1998 -NZ$8.83 Million10.64%
1997 -NZ$7.98 Million-9.62%
1996 -NZ$8.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$26.77 B-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.96 B-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$24.87 B-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.98 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$41.5 M-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.20 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.73 Million-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.78 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA